Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DARATUMUMAB Cause Platelet count decreased? 502 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 502 reports of Platelet count decreased have been filed in association with DARATUMUMAB (DARZALEX). This represents 1.8% of all adverse event reports for DARATUMUMAB.

502
Reports of Platelet count decreased with DARATUMUMAB
1.8%
of all DARATUMUMAB reports
91
Deaths
164
Hospitalizations

How Dangerous Is Platelet count decreased From DARATUMUMAB?

Of the 502 reports, 91 (18.1%) resulted in death, 164 (32.7%) required hospitalization, and 43 (8.6%) were considered life-threatening.

Is Platelet count decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DARATUMUMAB. However, 502 reports have been filed with the FAERS database.

What Other Side Effects Does DARATUMUMAB Cause?

Plasma cell myeloma (2,980) Infusion related reaction (2,557) Off label use (2,494) Pneumonia (1,450) Neutropenia (1,351) Drug ineffective (1,110) Thrombocytopenia (1,089) Death (1,088) Pyrexia (1,032) Dyspnoea (996)

What Other Drugs Cause Platelet count decreased?

LENALIDOMIDE (7,491) NIRAPARIB (4,102) ELTROMBOPAG OLAMINE (3,419) RUXOLITINIB (3,028) RITUXIMAB (2,404) VENETOCLAX (2,367) DEXAMETHASONE (2,321) PALBOCICLIB (2,277) CYCLOPHOSPHAMIDE (1,894) RIBAVIRIN (1,701)

Which DARATUMUMAB Alternatives Have Lower Platelet count decreased Risk?

DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ DARATUMUMAB vs DARBEPOETIN ALFA DARATUMUMAB vs DARIDOREXANT DARATUMUMAB vs DARIFENACIN HYDROBROMIDE DARATUMUMAB vs DAROLUTAMIDE

Related Pages

DARATUMUMAB Full Profile All Platelet count decreased Reports All Drugs Causing Platelet count decreased DARATUMUMAB Demographics